The document discusses science entrepreneurship and examples of scientists who have become wealthy entrepreneurs. It provides several case studies of scientists who started successful companies in fields like pharmaceuticals, biotechnology, computers, and telecommunications. It discusses how universities are becoming more entrepreneurial and how this is allowing some scientists to earn substantial fortunes by commercializing their research through new companies.
CAMentrepreneurs IP for international markets 24th June 2020 - onlineRichard Lucas
This CAMentrepreneurs event was organised by Claudia Duffy as per here https://camentrepreneurs17.eventbrite.co.uk
with hosting by Richard Lucas, Founder www.linkedin.com/in/richardhlucas
Dr. Claudia M. Duffy, CAMentrepreneurs Scotland https://www.linkedin.com/in/dr-claudia-m-duffy-8036191b/
Robert Howells, CAMentrepreneurs New York https://www.linkedin.com/in/robertlhowells/
The IP US specialist – Dr. James R. Major, Associate, Norris McLaughlin Attorneys at Law (New York, USA) https://norrismclaughlin.com/attorney_profiles/james-r-major/
and
The China and Hong Kong specialist - Anna Mae Koo, Partner, Vivien Chan & Co (Beijing, China and Hong Kong) http://www.vcclawservices.com/index.php?cid=66
Zoom Channel introductions https://docs.google.com/document/d/1GGyQW0ObQlXvXR1W8w599pup4n05KQ4--paKDCF_o1k/edit?ts=5ef3f1f2
CAMentrepreneurs https://www.alumni.cam.ac.uk/group/camentrepreneurs
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'Fundación Ramón Areces
Los días 13 y 14 de marzo de 2014, la Fundación Ramón Areces organizó con el Instituto de Estudios de la Innovación (IREIN) y el Foro de Empresas Innovadoras una jornada sobre 'Nuevos enfoques sobre políticas de innovación'. Contó con la intervención de destacados expertos internacionales como Luc Soete, rector de la Universidad de Maastricht; Julia Lane, del American Institutes for Research (AIR) de Estados Unidos; Giovanni Dosi, del Institute of Economics de la Scuola Superiore Sant'Anna (Italia); Daniele Archibugi, del CNRS y del Birkbeck College de la University of London; John Cantwell, del Rutgers Business School de Rutgers University (Estados Unidos); Jorge Katz, de la Universidad de Chile; Tom Hockaday, del ISIS Innovation de la Universidad de Oxford (Reino Unido), y Johan Schot, del Science and Technology Policy Research de la University of Sussex (Reino Unido).
Academic Scientist: Big Pharma is not Interested by your Discovery?Ari Massoudi
I received a newsletter in my email box in which there was a TV reportage saying:
"Cancer is finally cured in Canada but Big Pharma has no interest! The fact that the international drug & medical industry have no interest is because the cure is really cheaper than a chocolate bar and it won't get them to gain any profits at all."
CAMentrepreneurs IP for international markets 24th June 2020 - onlineRichard Lucas
This CAMentrepreneurs event was organised by Claudia Duffy as per here https://camentrepreneurs17.eventbrite.co.uk
with hosting by Richard Lucas, Founder www.linkedin.com/in/richardhlucas
Dr. Claudia M. Duffy, CAMentrepreneurs Scotland https://www.linkedin.com/in/dr-claudia-m-duffy-8036191b/
Robert Howells, CAMentrepreneurs New York https://www.linkedin.com/in/robertlhowells/
The IP US specialist – Dr. James R. Major, Associate, Norris McLaughlin Attorneys at Law (New York, USA) https://norrismclaughlin.com/attorney_profiles/james-r-major/
and
The China and Hong Kong specialist - Anna Mae Koo, Partner, Vivien Chan & Co (Beijing, China and Hong Kong) http://www.vcclawservices.com/index.php?cid=66
Zoom Channel introductions https://docs.google.com/document/d/1GGyQW0ObQlXvXR1W8w599pup4n05KQ4--paKDCF_o1k/edit?ts=5ef3f1f2
CAMentrepreneurs https://www.alumni.cam.ac.uk/group/camentrepreneurs
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'Fundación Ramón Areces
Los días 13 y 14 de marzo de 2014, la Fundación Ramón Areces organizó con el Instituto de Estudios de la Innovación (IREIN) y el Foro de Empresas Innovadoras una jornada sobre 'Nuevos enfoques sobre políticas de innovación'. Contó con la intervención de destacados expertos internacionales como Luc Soete, rector de la Universidad de Maastricht; Julia Lane, del American Institutes for Research (AIR) de Estados Unidos; Giovanni Dosi, del Institute of Economics de la Scuola Superiore Sant'Anna (Italia); Daniele Archibugi, del CNRS y del Birkbeck College de la University of London; John Cantwell, del Rutgers Business School de Rutgers University (Estados Unidos); Jorge Katz, de la Universidad de Chile; Tom Hockaday, del ISIS Innovation de la Universidad de Oxford (Reino Unido), y Johan Schot, del Science and Technology Policy Research de la University of Sussex (Reino Unido).
Academic Scientist: Big Pharma is not Interested by your Discovery?Ari Massoudi
I received a newsletter in my email box in which there was a TV reportage saying:
"Cancer is finally cured in Canada but Big Pharma has no interest! The fact that the international drug & medical industry have no interest is because the cure is really cheaper than a chocolate bar and it won't get them to gain any profits at all."
The literature review is not merely a simple compilation or a list of every item and resource with any possible relation to your topic. A good literature review is a critical appraisal of narrowly focused, selected and truly relevant work that provides the current status (perspective) of the topic. This presentation basically is a brief guide on the process of doing and writing a literature review for a thesis, research proposal, research paper, etc.
Pitches from the 10 finalist teams selected to compete for the £100,000 Grand Prize of the inaugural OneStart competition in 2013, hosted by the Oxbridge Biotech Roundtable and SR One.
Learn more about this year's competition: http://oxbridgebiotech.com/onestart
Presentation of Simon Howell (Founding Non-Executive Director of MedCity and Guy’s Campus Dean at King’s College London King’s College London) at the Forum of the BioRegion of Catalonia, organized by Biocat.
The literature review is not merely a simple compilation or a list of every item and resource with any possible relation to your topic. A good literature review is a critical appraisal of narrowly focused, selected and truly relevant work that provides the current status (perspective) of the topic. This presentation basically is a brief guide on the process of doing and writing a literature review for a thesis, research proposal, research paper, etc.
Pitches from the 10 finalist teams selected to compete for the £100,000 Grand Prize of the inaugural OneStart competition in 2013, hosted by the Oxbridge Biotech Roundtable and SR One.
Learn more about this year's competition: http://oxbridgebiotech.com/onestart
Presentation of Simon Howell (Founding Non-Executive Director of MedCity and Guy’s Campus Dean at King’s College London King’s College London) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Stacking the Odds for Success: A Six-Stage Process to Articulate and Promote Your Entrepreneurial Idea
Jon Obermeyer
Jon Obermeyer, Director of External Education and Outreach at Wake Forest University Institute for Regenerative Medicine, and former CEO of the Piedmont Triad Entrepreneurial Network (PTEN), will be our dynamic lunchtime speaker providing us with a toolkit for developing entrepreneurial ideas.
Entrepreneurs seeking venture capital follow a standard format for attracting outside investment, using six topic areas to describe concisely and compellingly the viability of a new product or service. This same process can be used for library professionals to articulate and promote their innovative concept to peers, administrators and strategic partners. Return-on-investment for this session will include an understanding of what makes a new idea compelling and more likely to be successful in execution, as well as a one-page template participants can use following the conference.
Through an open call, progressive organizations can fast-track R&D and traditional product development by reaching out to some of the world's most creative thinkers—icitizens who thrive on solving tough challenges and accelerating change.
The Success And Future Of Daresbury Sic Corporate 300310JohnLeake
Overview of Daresbury Science and Innovation Campus and its novel model based on open innovation to drive greater commercial exploitation of technology
The Commercialising Metamaterials Innovation Network brings you its next workshop in our winter series. This webinar will bring together a variety of experts who can offer organisations the support they need to successfully scale up and commercialise.
Once an aspect of metamaterials technology has been identified with the potential in a particular application, there is a need to look to scale up the production to develop demonstrators and prototypes. This activity is often associated with a start-up or SME since the technology is brought in from research. The needs of these small enterprises in progressing, from this first step to commercialisation, can include a variety of services offered from academia to investors. Very often investors will only be interested in further steps to commercialise or upscale.
This webinar will bring together a variety of experts who can offer organisations the support they need to successfully scale up and commercialise. This includes modelling services from academia; advanced manufacturing scale up from catapults and academia; innovation funding and investor access from Government-funded organisations; early-stage design expertise to ensure capture of best product and application, to name just a few.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Prague lecture
1. Science entrepreneurship – making it big? Dr Lorraine Warren School of Management, University of Southampton February 3, 2011, English College in Prague
17. Collaboration Merck <-> UoS Merck building Has physics and chemistry laboratories on the upper floor and offices on the ground floor for research into liquid crystals.
18.
19. Resources Level of Development Existing Research and Development Resources Existing Commercialization Resources Discovery TFP Product Development Commercialization The Valley of Death
20. Resources Level of Development Existing Research Resources (Technical and Market) Existing Commercialization Resources Discovery FFE Development Commercialization Technology Feasibility Point Decision space between opportunity discovery and product development Area of Study
21. Gap between Research and Commercial Application: Targeting resources where they have the greatest impact on new business creation Resources Research Faculty Service Providers / Complementary Assets Level of Development “ Valley of Death” Existing Research Resources Existing Commercialization Resources Decision space between discovery and product development
22.
23.
24.
25.
26. T P P P P P M M M M M M M M M The most basic building block of a Business Concept Why is it difficult?: Technology - Product - Market Linkages
27. The TEC Algorithm (Professor Angus Kingon, NCSU) Description / Ideation Commercialization Strategy Commercialization Implementation Database or Further Development Phase I Phase II
28. The TEC Algorithm Information Gathering Description / Ideation Commercialization Strategy Commercialization Implementation Database or Further Development Phase I Phase II
29. Launch Funding Sr Mgmt Strategy Development Primary Information Gathering Preliminary Assessment Product Concept Product Formulation Preliminary Assessment Primary Information Gathering Strategy Development Implementation